Convatec Group PLC
CTEC: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| P>t | LOCK|W^<<! | LOCK|j!dX&^ |
Convatec Earnings: Well Positioned for Acceleration Beyond 2026; Shares Undervalued
Convatec reported first-half organic sales growth, excluding InnovaMatrix's 5% growth, with adjusted operating margin expanding to 21.8% from 21.3% in constant currencies. Management reiterated its full-year guidance of 5.5%-6% organic sales growth, excluding InnovaMatrix.
